Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.37 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93766 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL391028 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674512 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674893 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6130185 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| Glycylglycylglycine SCHEMBL98565 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6677616 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL391787 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6120072 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL4586328 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 636 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111778169-B | Method for improving in vitro protein synthesis efficiency | 康码（上海）生物科技有限公司 | 2023-02-10 | — | — | CN | claimed |
| CN-108430489-B | Fusion proteins for inhibiting angiogenesis | 新源生物科技股份有限公司 | 2022-03-25 | — | — | CN | claimed |
| US-20220048988-A1 | CELLS EXPRESSING ANTIBODIES TARGETING HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USING THE SAME | CHILDREN'S NATIONAL MEDICAL CENTER | 2022-02-17 | — | — | US | claimed |
| CN-103987728-B | Anti-cancer fusion protein | 阿达梅德公司 | 2017-05-10 | — | — | CN | claimed |
| US-8080254-B2 | OB fusion protein compositions and methods | AMGEN, INC. (US) | 2011-12-20 | — | — | US | claimed |
| CN-100471873-C | A series of polypeptide capable of blocking IL-6 and its medicinal uses | BO YU (CN) | 2009-03-25 | — | — | CN | claimed |
| US-20080058505-A1 | PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules | GARDELLA THOMAS J | 2008-03-06 | — | — | US | claimed |
| US-20070224193-A1 | METHODS OF INCREASING LEAN TISSUE MASS USING OB PROTEIN COMPOSITIONS | AMGEN, INC. (US) | 2007-09-27 | — | — | US | claimed |
| US-20070020284-A1 | OB fusion protein compositions and methods | AMGEN, INC. (US) | 2007-01-25 | — | — | US | claimed |
| EP-0954588-B1 | OB FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC (US) | 2007-01-17 | — | — | EP | claimed |
| EP-1147133-A4 | PTH FUNCTIONAL DOMAIN CONJUGATE PEPTIDES, DERIVATIVES THEREOF AND NOVEL TETHERED LIGAND-RECEPTOR MOLECULES | GEN HOSPITAL CORP (US) | 2003-02-12 | — | — | EP | claimed |
| WO-2002022821-A2 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2002-03-21 | — | — | WO | claimed |
| CN-1335888-A | OPG fusion protein compositions and methods | AMGEN INC (US) | 2002-02-13 | — | — | CN | claimed |
| EP-1147133-A2 | PTH FUNCTIONAL DOMAIN CONJUGATE PEPTIDES, DERIVATIVES THEREOF AND NOVEL TETHERED LIGAND-RECEPTOR MOLECULES | THE GENERAL HOSPITAL CORPORATION (US) | 2001-10-24 | — | — | EP | claimed |
| EP-1127117-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | Amgen Inc., (US) | 2001-08-29 | — | — | EP | claimed |
| WO-2001018203-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2001-03-15 | — | — | WO | claimed |
| WO-2000063253-A1 | AGP-1 FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2000-10-26 | — | — | WO | claimed |
| WO-2000039278-A2 | PTH FUNCTIONAL DOMAIN CONJUGATE PEPTIDES, DERIVATIVES THEREOF AND NOVEL TETHERED LIGAND-RECEPTOR MOLECULES | THE GENERAL HOSPITAL CORPORATION (US) | 2000-07-06 | — | — | WO | claimed |
| WO-1994019465-A2 | NOVEL DNA- BINDING REGULATOR OF c-myc EXPRESSION WHICH BINDS TO THE FAR UPSTREAM ELEMENTS (FUSE) AND cDNA THEREFOR | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTHAND HUMAN SERVICES (US) | 1994-09-01 | — | — | WO | claimed |
| WO-1993001284-A1 | RECOMBINANT VIRAL VACCINE | CORNELL RESEARCH FOUNDATION, INC. (US) | 1993-01-21 | — | — | WO | claimed |